Novobind Livestock Therapeutics Inc. is an integrated animal health company based in Vancouver, Canada, focused on developing next-generation biologics to combat pathogens that significantly impact livestock, aquaculture, and pets. Founded in 2012, the company addresses the challenges of rising resistance to anti-infectives and the accumulation of harmful residues in the environment. By targeting specific bacteria, viruses, and parasites responsible for intestinal ailments, Novobind aims to reduce production losses exceeding $1 billion and improve food safety for producers. Through its innovative approach, the company supports the animal sector in minimizing waste and enhancing health outcomes for various animal populations.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.